Press Release EHang Holdings Limited Alert: Shareholders with Significant Losses in EH Should Contact Robbins LLP About Their Rights and Remedies 15 December 2023
Press Release FDA Approves Expanded Indication for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) for the First-Line Treatment of Adult Patients With Locally Advanced or Metastatic Urothelial Cancer 15 December 2023
Press Release Cathedra Bitcoin Announces Closing of Debt Settlement and Debenture Extension 15 December 2023
Press Release Blue Ridge Bankshares, Inc.: Shareholders with Significant Losses in BRBS Should Contact Robbins LLP About Their Rights and Remedies 15 December 2023
Press Release Bristol Myers Squibb Provides Update on RELATIVITY-123 Trial Evaluating the Fixed-Dose Combination of Nivolumab and Relatlimab in Patients with Previously Treated Metastatic Microsatellite Stable (MSS) Colorectal Cancer 15 December 2023
Press Release reAlpha Tech Corp. Announces Second Quarter 2023 Results and Provides Business Update 15 December 2023
